Atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) are nonmalignant breast
lesions that confer a 4-to 10-fold increased risk for breast cancer in women. Often, AH and …

Women with lobular carcinoma in situ (LCIS), atypical lobular hyperplasia (ALH), atypical
ductal hyperplasia (ADH), or atypical hyperplasia (AH) are at increased breast cancer (BC) …

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) represent a
spectrum of breast disease referred to as" lobular neoplasia"(LN). Although LN occurs …

Lobular neoplasia broadly defines the spectrum of changes within the lobule, ranging from
atypical lobular hyperplasia (ALH) to lobular carcinoma in situ (LCIS). This continuum of …

The term lobular neoplasia refers to a spectrum of lesions featuring atypical lobular
hyperplasia and lobular carcinoma in situ (LCIS). The histopathological characteristics of …

Background The risk of breast cancer in young women diagnosed with atypical hyperplasia
and (LCIS) is not well defined. The objectives were to evaluate outcomes and to help …

Atypical hyperplasia and lobular carcinoma in situ are rare proliferative breast lesions,
growing inside ducts and terminal ducto-lobular units. They represent a marker of increased …

OBJECTIVES: To determine the incidence of malignancy (invasive carcinoma or DCIS) in
patients diagnosed with lobular neoplasia (B3) on core needle biopsy (CNB) of breast …

Abstract Purpose of Review The aim of this review is to summarize recently published
literature addressing atypical ductal hyperplasia (ADH), lobular neoplasia (atypical lobular …

The only clear conclusion that can be made based on published literature about the
appropriate management of lobular carcinoma in situ (LCIS) and atypical lobular …